Seaside Therapeutics

HOME      CAREERS      SITEMAP      CONTACT US

    Autism and Fragile X Art Gallery

Novel Therapies for patients with Autism and Fragile X Syndrome

Seaside Therapeutics is creating new drug treatments to correct or improve the course of
Fragile X Syndrome, autism and other disorders of
brain development. We are dedicated to translating breakthrough discoveries in neurobiology into therapeutics that improve the lives of patients and
their families.

....


      pdfDownload Corporate Fact Sheet

Latest News

January 6, 2010
Seaside Therapeutics and Vanderbilt University Enter Collaborative Research Agreement to Discover Novel Therapeutics to Treat Disorders of Brain Development

December 16, 2009
Seaside Therapeutics Appoints Tanya Lewis to the Key Position of Vice President, Regulatory Affairs and Quality Assurance

November 2, 2009
"Stabilizing Fragile X" by Michael Flanagan, Senior Writer, BioCentury, Page A6